Literature DB >> 30121899

Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism.

Ting Chen1, Qing Li2, Jiao Wu2, Yaxin Wu2, Wei Peng2, Huan Li2, Jianmei Wang3, Xiaowei Tang2, Yan Peng2, Xiangsheng Fu4.   

Abstract

Fusobacterium nucleatum (Fn) has been shown to promote colorectal cancer (CRC) development by inhibiting host anti-tumour immunity. However, the impact of Fn infection on macrophage polarization and subsequent intestinal tumour formation as well as the underlying molecular pathways has not been investigated. We investigated the impact of Fn infection on macrophage polarization in human CRCs and cultured macrophages as well as the effects on macrophage phenotype and intestinal tumour formation in ApcMin/+ mice. We also examined whether macrophage-polarized activation challenged by Fn infection via a TLR4-dependent mechanism involved the IL-6/STAT3/c-MYC signalling cascade. Our data showed that macrophages are a major tumour-infiltrating immune cell type in human CRCs with Fn infection (P < 0.001). Fn infection increased M2 polarization of macrophages in vitro and in vivo, leading to intestinal tumour growth in ApcMin/+ mice. Moreover, Fn infection induced high expression of TLR4, IL-6, STAT3, p-STAT3, and c-MYC in cultured macrophages challenged with Fn, which was blocked by TAK-242 pre-treatment (P < 0.05). Interestingly, c-MYC protein was mainly co-localized with CD206+ M2 macrophages with Fn infection. In conclusion, we show that Fn infection increased M2 polarization of macrophages in vitro and in vivo. Furthermore, Fn infection enhanced colorectal tumour growth in a TLR4-dependent manner involving activation of the IL-6/p-STAT3/c-MYC signalling pathway. For the first time, our results indicate an immunosuppressive effect of Fn by promoting M2 polarization of macrophages through a TLR4-dependent mechanism, which may serve as a promising target for immunotherapy of Fn-related CRC.

Entities:  

Keywords:  Colorectal cancer; Fusobacterium nucleatum; Immune; Macrophages; Toll-like receptor 4

Mesh:

Substances:

Year:  2018        PMID: 30121899     DOI: 10.1007/s00262-018-2233-x

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  42 in total

1.  Autoinducer-2 of gut microbiota, a potential novel marker for human colorectal cancer, is associated with the activation of TNFSF9 signaling in macrophages.

Authors:  Qing Li; Wei Peng; Jiao Wu; Xianfei Wang; Yixing Ren; Huan Li; Yan Peng; Xiaowei Tang; Xiangsheng Fu
Journal:  Oncoimmunology       Date:  2019-06-10       Impact factor: 8.110

2.  Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status.

Authors:  Ji Ae Lee; Seung-Yeon Yoo; Hyeon Jeong Oh; Seorin Jeong; Nam-Yun Cho; Gyeong Hoon Kang; Jung Ho Kim
Journal:  Cancer Immunol Immunother       Date:  2020-07-04       Impact factor: 6.968

Review 3.  The interaction between gut microbiome and anti-tumor drug therapy.

Authors:  Chen Fu; Ziting Yang; Jiankun Yu; Minjie Wei
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

4.  Engineering Human Circulating Monocytes/Macrophages by Systemic Deliverable Gene Editing.

Authors:  So Yoon Lee; Javier Fierro; Jake Dipasquale; Anthony Bastian; An M Tran; Deawoo Hong; Brandon Chin; Paul J Nguyen-Lee; Sarah Mazal; Jamil Espinal; Tima Thomas; Huanyu Dou
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

Review 5.  Roles of exosomal circRNAs in tumour immunity and cancer progression.

Authors:  Baojing Tuo; Zhuang Chen; Qin Dang; Chen Chen; Hao Zhang; Shengyun Hu; Zhenqiang Sun
Journal:  Cell Death Dis       Date:  2022-06-09       Impact factor: 9.685

Review 6.  Targeting the gut and tumor microbiota in cancer.

Authors:  Elizabeth M Park; Manoj Chelvanambi; Neal Bhutiani; Guido Kroemer; Laurence Zitvogel; Jennifer A Wargo
Journal:  Nat Med       Date:  2022-04-19       Impact factor: 87.241

7.  Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?.

Authors:  Pu Xiaoyu; Ge Chao; Dong Lihua; Chang Pengyu
Journal:  Gut Microbes       Date:  2020-03-27

Review 8.  Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy.

Authors:  Runqi Zhu; Tianqun Lang; Wenlu Yan; Xiao Zhu; Xin Huang; Qi Yin; Yaping Li
Journal:  Adv Sci (Weinh)       Date:  2021-03-09       Impact factor: 16.806

Review 9.  Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?

Authors:  Nuttavut Sumransub; Kornpong Vantanasiri; Ajay Prakash; Emil Lou
Journal:  Mol Ther Oncolytics       Date:  2021-05-14       Impact factor: 7.200

10.  Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling.

Authors:  Qing Li; Wei Wu; Dexin Gong; Renduo Shang; Jing Wang; Honggang Yu
Journal:  Gastric Cancer       Date:  2021-06-02       Impact factor: 7.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.